Andere Sprachen AVITA Medical, Inc.

Aktien

A2P733

US05380C1027

RCEL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.05.2024			% 5 Tage	% 1. Jan.
8.14 ^USD	-0.37%		-6.65%	-40.67%

14.05.	AVITA MEDICAL, INC. : Cantor Fitzgerald bekräftigt seine Kaufempfehlung	ZM
14.05.	AVITA MEDICAL, INC. : Von Piper Sandler auf neutral herabgestuft	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AVITA Medical to Host Investor Webinar Briefing	17.05.
Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	14.05.
AVITA Medical Reports First Quarter Financial Results	13.05.
AVITA Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
AVITA Medical to Announce First Quarter 2024 Financial Results	15.04.
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	11.04.
AVITA Medical Updates Expected First Quarter 2024 Revenue	10.04.
AVITA Medical, Inc. Revises Revenue Guidance for the First Quarter Ended March 31, 2024 and Full Year Fiscal 2024	10.04.
AVITA Medical, Inc.(ASX:AVH) added to S&P/ASX All Ordinaries Index	18.03.
AVITA Medical, Inc.(NasdaqCM:RCEL) added to S&P Biotechnology Select Industry Index	18.03.
AVITA Medical Submits Additional RECELL GO PMA Supplement Information to US FDA	01.03.
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement	29.02.
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference	29.02.
Morgans rates AVH as Add	26.02.
AVITA Medical to Host Investor Webinar Briefing	23.02.
AVITA Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	22.02.
AVITA Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
AVITA Medical, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	22.02.
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AVITA Medical, Inc.

Aktien

A2P733

US05380C1027

RCEL

Andere Sprachen

Filter